Diabetes Mellitus, Type 2 Clinical Trial
— PerPA2TempsOfficial title:
Psychological Levers of Commitment and Persistence in Physical Activity in People With Type 2 Diabetes. PerPA2Temps Study
Verified date | December 2022 |
Source | Siel Bleu |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Many programmes exist to enable patients to engage in physical activity, but it is clear that the objectives are often not achieved in terms of quality, quantity or intensity of practice. In this study, the aim is to find alternatives, assuming that strengthening patients' self-efficacy, meeting their basic needs and increasing their level of hope will have an impact on their motivation to practice, which in turn will have an impact on their actual practice. The aim is to develop and implement an innovative intervention programme and to identify the interactions between the variables that are assumed to predict engagement in practice.
Status | Active, not recruiting |
Enrollment | 77 |
Est. completion date | April 2023 |
Est. primary completion date | April 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Subject over 18 years of age - Subject who has given signed consent to participate in the protocol - Type 2 diabetic subject not treated with insulin - Subject participating for the first time in adapted physical activity sessions provided by Siel Bleu - Subject understanding and reading French Exclusion Criteria: - Subjects with major health problems that prevent them from continuing the programme. - Subjects who have withdrawn their consent. |
Country | Name | City | State |
---|---|---|---|
France | Elise Maudet-Coulomb | Angers | Maine Et Loire |
Lead Sponsor | Collaborator |
---|---|
Siel Bleu |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in amount of physical activity assessed by the French Version of GPAQ | The evolution of the quantity of physical activity will be the main criterion of judgment. It will be measured by the Global Physical Activity Questionnaire, which will allow for differentiation of intensities and contexts of practice. This questionnaire will be administered at each evaluation time proposed by the study (before/after, at 3, 6 and 12 months). The higher the score (in Metabolic Equivalent of Task/minutes/weeks), the greater the amount and intensity of physical activity performed.
The comparison between the pre- and post-programme assessments (e.g. T0 and T1) will allow the direct effect of the programme on the amount of physical activity to be determined. The other assessments (e.g. T2, T3 and T4) will determine the persistence of this practice over time. |
Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention | |
Secondary | Change in the subjects' motivational profile towards a more self-determined motivation assessed by the French Version of the Motivation for Physical Activity for Health Scale | To assess the motivation of the subjects, the Motivation for Physical Activity for Health Scale will be used. It measures the quality of contextual motivation with three items per dimension (intrinsic motivation, integrated regulation, identified regulation, introjected regulation, external regulation and amotivation). Subjects will respond with a 7-point Likert scale ranging from 1 (does not match at all) to 7 (matches very strongly). | Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention | |
Secondary | Change in the satisfaction of basic psychological needs assessed by the French Version of The Basic Psychological Needs. | The Basic Psychological Needs in Sport questionnaire assesses the three dimensions of basic psychological needs using five items per need: satisfaction of the need for autonomy (e.g., I feel free to make my own choices), satisfaction of the need for affiliation (e.g., I feel comfortable with others), and satisfaction of the need for competence (e.g., I feel successful). Subjects will respond using a Likert scale ranging from 1 (not at all true) to 7 (completely true). This questionnaire will be administered at each evaluation time proposed by the study. | Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention | |
Secondary | Change in self-efficacy assessed by the French Version of The Self-Efficacy Questionnaire | The Self-Efficacy Questionnaire (SEP) is composed of 40 items corresponding to cognitive-emotional and behavioural conditions. These 40 items are divided into four categories, each based on 10 descriptors of SEP manifestations: management of eating behaviour, physical activity, body image and the gaze of others, and social relations. Subjects are asked to respond on a Likert-type scale ranging from 0 to 10 and to indicate a score out of 10 from "not at all capable" to "very capable". This score yields five scores; one for each difficulty, calculated over 10 items. An overall score is calculated out of 40. | Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention | |
Secondary | Change of initial state hope level assessed by the French Version of the State Hope Scale | The level of state hope is measured by a self-administered questionnaire. In this questionnaire, the total hope score is calculated using six items, three of which correspond to the motivational component and three to the operative component. Responses to these items are based on a six-point Likert-type scale, ranging from 1 (Strongly disagree) to 6 (Strongly agree). The total state expectancy score will be evaluated on 36 points. The operant and motivational component sub-scores will be assessed on 18 points each. | Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention | |
Secondary | Change in dispositional hope level assessed by the French Version of the Adult Dispositional Hope Scale | This self-evaluation scale is composed of 12 items corresponding to three different categories: the operative component includes four items, the motivational component also includes four items, and the remaining four items are decoys. Subjects will be able to respond to the questions using a Likert scale ranging from 1 (Always false) to 8 (Always true). The total dispositional hope score will be between 8 and 64 points. The operant and motivational component subscores will range from 4 to 32 points each. | Pre-intervention/immediately after the intervention | |
Secondary | Change in dispositional optimism level assessed by the French Version of The Life Orientation Test-Revised | The Life Orientation Test-Revised is composed of 10 items corresponding to three categories: positive expectations associated with three items, negative expectations represented by three items, and the other four items corresponding to decoys. The subjects will answer the questionnaires on their own using a Likert scale ranging from 0 (Totally Disagree) to 4 (Totally Agree). This questionnaire provides an overall optimism score as well as two sub-scores corresponding to positive and negative expectations. | Pre-intervention/immediately after the intervention | |
Secondary | Change in physical condition assessed by The 6-Minute Walk Test | The 6-Minute Walk Test is a standardised test to measure exercise capacity in an objective way. In this test, the subject is asked to walk as far as possible for six minutes. Several data are then collected: distance covered (in metres), oxygen saturation, heart rate (in beats per minute) and degree of breathlessness (on a Borg scale ranging from 1 to 10). For our study, heart rate (HR) and degree of breathlessness will be collected before the test, just after and one minute after the end of the test. During the test, the subject will be kept informed of the time remaining every minute. At the same time, the subject will receive encouragement (i.e. "That's very good, keep it up"). | Pre-intervention/immediately after the intervention | |
Secondary | Subject attendance assessed by an attendance grid | Completed by the facilitator, the number of participants at each session, attendance (presence or absence of each participant at each session), completion of active challenges and weekly positive reinforcement exercises is recorded. | Through intervention completion, that is, 12 weeks | |
Secondary | Participant satisfaction assessed by a study-specific questionnaire | The satisfaction questionnaire assesses different aspects of the programme. Questions about the physical activity sessions will be asked (i.e. satisfaction with the content, diversity, user-friendliness, etc.). Satisfaction with the facilitator will also be assessed (i.e. ability to adapt the exercises, to motivate the group, to promote autonomy, etc.). The benefits of the programme will be judged on the basis of various categories (i.e. physical, biological, psychological and social). Participants will have the opportunity to rate the programme on a scale of 1 to 10 (10 being the highest) and to leave various comments. For those who benefited from the specific programme under study, the questionnaire includes an additional module to assess satisfaction with the active challenges, the positive reinforcement exercises and the information and experience sharing group. | Immediately after the intervention | |
Secondary | Individual demographic and socio-economic data assessed by a specific form for the study | The subject completes an information sheet including: age, gender, level of education, socio-professional category, and place of residence. | Pre-intervention | |
Secondary | Initial medical data assessed by a specific form for the study | The subject completes an information sheet including: personal and family history and height (in centimetres) | Pre-intervention | |
Secondary | Progressive medical data assessed by a specific form for the study | The subject completes an information sheet including: weight (in kilograms), treatment type and glycated haemoglobin (in %) | Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 | |
Completed |
NCT02897349 -
Linagliptin Add-on to Insulin Background Therapy
|
Phase 3 |